Alanine for Proline Substitution in the Peroxisome Proliferator–Activated Receptor Gamma-2 (PPARG2) Gene and the Risk of Incident Myocardial Infarction
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (5) , 859-863
- https://doi.org/10.1161/01.atv.0000068680.19521.34
Abstract
Objective— Recent studies have implicated the potential importance of peroxisome proliferator–activated receptors as a molecular mechanism involved in atherothrombosis. A common alanine (A) for proline (P) substitution at codon 12 in the peroxisome proliferator activated receptor gamma-2 gene (PPARG2) has been associated with reduced risk of developing type 2 diabetes mellitus. Because diabetes and atherothrombosis share common antecedents, we sought evidence that this polymorphism might also be associated with reduced risk of myocardial infarction. Methods and Results— Using DNA samples collected at baseline in a prospective cohort of 14 916 initially healthy American men, we evaluated a P12A polymorphism in the PPARG2 among 523 individuals who subsequently developed myocardial infarction and among 2092 individuals who remained free of reported cardiovascular disease over a mean follow-up period of 13.2 years. As hypothesized, presence of the A12 allele was associated with significantly reduced risk of m...Keywords
This publication has 19 references indexed in Scilit:
- Insights into obesity and insulin resistance from the study of extreme human phenotypesActa Endocrinologica, 2002
- Do atherosclerosis and type 2 diabetes share a common inflammatory basis?European Heart Journal, 2002
- Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigmsCurrent Atherosclerosis Reports, 2000
- Inhibitory Effect of a Proline-to-Alanine Substitution at Codon 12 of Peroxisome Proliferator-Activated Receptor-γ 2 on Thiazolidinedione-Induced AdipogenesisBiochemical and Biophysical Research Communications, 2000
- Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ ActivatorsCirculation, 2000
- Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertensionNature, 1999
- Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery diseasePublished by Oxford University Press (OUP) ,1999
- Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor yCurrent Opinion in Lipidology, 1999
- Assessment of genetic markers for coronary thrombosis: promise and precautionThe Lancet, 1999
- A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivityNature Genetics, 1998